ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Duo of VHIO projects awarded by AGAUR and EU’s ERDF

14/08/2020|Comments Off on Duo of VHIO projects awarded by AGAUR and EU’s ERDF

In consensus: ESMO’s clinical statements to steer optimal cancer treatment and care in the COVID-19 era

06/08/2020|Comments Off on In consensus: ESMO’s clinical statements to steer optimal cancer treatment and care in the COVID-19 era

ecancer catches up with VHIO’s Joaquin Mateo on the latest developments in PARPi against prostate cancer

05/08/2020|Comments Off on ecancer catches up with VHIO’s Joaquin Mateo on the latest developments in PARPi against prostate cancer

Comprehensive tour de force signposts directions to deliver on Horizon 2020’s Cancer Mission

04/08/2020|Comments Off on Comprehensive tour de force signposts directions to deliver on Horizon 2020’s Cancer Mission

VHIO and ‘home-grown’ spin-off Peptomyc S.L receive further funding to bring Omomyc closer to the clinic

30/07/2020|Comments Off on VHIO and ‘home-grown’ spin-off Peptomyc S.L receive further funding to bring Omomyc closer to the clinic

Vall d’Hebron Institute of Oncology Named a Syneos Health Catalyst Site

30/07/2020|Comments Off on Vall d’Hebron Institute of Oncology Named a Syneos Health Catalyst Site

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2018

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS